Table I Index
Table of Contents

Table I - 69
Ripley
Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana

Primary Site

Total

Males Females
Number Rate Number Rate Number Rate
All sites 127 403.2 61 437.2 66 372.5
Oral cavity and pharynx * # * # * #
Lip * # * # * #
Tongue * # * # * #
Major salivary glands * # * # * #
Floor of mouth * # * # * #
Gum and other mouth * # * # * #
Nasopharynx * # * # * #
Tonsil * # * # * #
Oropharynx * # * # * #
Hypopharynx * # * # * #
Pharynx and other oral cavity * # * # * #
Digestive system 15 45.4** 8 55.2** 7 39.2**
Esophagus * # * # * #
Stomach * # * # * #
Small intestine * # * # * #
Colon excluding rectum 6 20.4** * # * #
Rectum and rectosigmoid 6 16.6** * # * #
Anus, anal canal, and anorectum * # * # * #
Liver and intrahepatic bile duct * # * # * #
Gallbladder * # * # * #
Other biliary * # * # * #
Pancreas * # * # * #
Retroperitoneum * # * # * #
Peritoneum * # * # * #
Other digestive organs * # * # * #
Respiratory system 24 84.8 15 114.3** 9 58.2**
Nasal cavity, ear, and sinuses * # * # * #
Larynx * # * # * #
Lung and bronchus 22 77.8 13 99.2** 9 58.2**
Trachea, pleura, and other respiratory organs * # * # * #
Bones and joints * # * # * #
Soft tissue (including heart) * # * # * #
Skin (excluding basal and squamous) * # * # * #
Melanoma of the skin * # * # * #
Other non-epithelial skin cancers * # * # * #
Breast 21 64.9 * # 21 119.5
Female genital system 14 40.7** -- -- 14 74.1**
Cervix uteri * # -- -- * #
Corpus uteri 7 20.3** -- -- 7 36.6**
Uterus, NOS * # -- -- * #
Ovary * # -- -- * #
Vagina * # -- -- * #
Vulva * # -- -- * #
Other female genital organs * # -- -- * #
Male genital system 19 58.8** 19 130.0** -- --
Prostate gland 16 51.3** 16 113.7** -- --
Testis * # * # -- --
Penis * # * # -- --
Other male genital organs * # * # -- --
Urinary system 9 28.1** * # 5 29.0**
Urinary bladder * # * # * #
Kidney and renal pelvis * # * # * #
Ureter * # * # * #
Other urinary organs * # * # * #
Eye and orbit * # * # * #
Brain and other nervous system * # * # * #
Brain * # * # * #
Other nervous system * # * # * #
Endocrine system * # * # * #
Thyroid gland * # * # * #
Other endocrine (including thymus) * # * # * #
Lymphoma 7 22.3** * # * #
Hodgkin’s disease * # * # * #
Non-Hodgkin’s lymphoma 5 15.6** * # * #
Multiple myeloma * # * # * #
Leukemia 6 19.5** * # * #
Acute lymphocytic * # * # * #
Chronic lymphocytic * # * # * #
Acute myeloid * # * # * #
Chronic myeloid * # * # * #
Other leukemias * # * # * #
Other, ill-defined and unknown sites * # * # * #

1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than twenty cases are unstable.
# Rate cannot be calculated.
_______________________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table I Index
Table of Contents

[an error occurred while processing this directive]